Presentation - Pharmacist Digest

Takeda presents positive results from trial of chronic kidney disease treatment

Pharmafile

JUNE 10, 2025

The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafile. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab.

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

STAT

JANUARY 22, 2025

” Experts told STAT there’s been a surge of interest for these compounds from biotech and pharma in the last few months, spurred on most by the presentation of promising clinical data from Summit Therapeutics.

Immunity

Immunity Immunization Compounding Drug Development

STAT+: How Pfizer used wearables to tap into the promise of an experimental drug

STAT

NOVEMBER 12, 2024

While the weight gain was significant, experts at the time said the study’s secondary endpoints, including patient-reported outcomes and physical activity measured by a wearable, presented a more nuanced portrait of how the treatment was influencing patients.

Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData

Express Pharma

DECEMBER 16, 2024

The post Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData appeared first on Express Pharma. Nevertheless, to address the unmet needs in CHE treatment, further research and clinical trials that focus on safety and the patients QoL are essential.

Levicept presents new LEVI-04 data at EULAR

Pharma Times

JUNE 12, 2025

The data were presented by Professor Philip Conaghan, Director of NIHR Leeds Biomedical Research Centre, during an oral session on June 14. Professor Philip Conaghan said: “These new data we are presenting at EULAR further support our belief that LEVI-04 has the potential to offer a vital new treatment option to millions of patients in need.”

STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present

STAT

SEPTEMBER 16, 2024

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published high-impact papers.

Opinion: Diagnostic tests for rare conditions present a mathematical conundrum

STAT

NOVEMBER 30, 2023

Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s.

Labelling

Argenx presents new efgartigimod data at EULAR 2025

Pharma Times

JUNE 11, 2025

Submit Latest content Bimekizumab shows lasting efficacy at EULAR 2025 Argenx presents new efgartigimod data at EULAR 2025 Tagomics secures £860k grant for colorectal cancer test PharmaTimes Clinical Researcher of the Year – The Americas EC approves Santen’s Ryjunea to slow progression of paediatric myopia Contact details PharmaTimes Media Ltd.

STAT+: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results

STAT

JUNE 20, 2025

The study, presented Friday at the American Diabetes Association’s scientific meeting and simultaneously published in the New England Journal of Medicine , updates previous research that followed these participants for a shorter period of time. After three months, none of them suffered severe bouts of low blood sugar.

Diabetes

STAT+: Cigna, Centene, Walgreens drop out of J.P. Morgan conference

STAT

JANUARY 13, 2025

Others that no longer appear on the final list of presenters: pharmacy chain Walgreens, medical device maker BD, insurer Oscar Health, physician practice management firm Agilon Health, medical device maker Inari Medical, biotech firm Applied Therapeutics, post-acute provider PACS, biotech firm IGM, and U.S. Morgan circulated on Dec.

Article presents innovative drug for controlling weight and blood sugar

World Pharma News

JUNE 25, 2025

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to produce heat through a process known as thermogenesis, thereby promoting weight loss.

Compounding

Experts say leaked messages present false link between gender-affirming care and cancer

STAT

MARCH 11, 2024

Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including cancer.

STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition

STAT

SEPTEMBER 3, 2024

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI drug developer.

Drug Development

Vertex presents promising new data from cystic fibrosis trials

Pharmafile

JUNE 9, 2025

Vertex Pharmaceuticals has presented new data showing the clinical and quality-of-life benefits of its cystic fibrosis (CF) therapies, particularly Alyftrek (deutivacaftor/tezacaftor/vanzacaftor). A combined […] The post Vertex presents promising new data from cystic fibrosis trials appeared first on Pharmafile.

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

MARCH 10, 2025

” Read the rest…

Mayo Clinic

Mayo Clinic Communication Hospitals

STAT+: New blood test could predict preeclampsia in the first trimester

STAT

JUNE 30, 2025

The findings are being presented Monday during the annual meeting of the European Society of Human Reproduction and Embryology, in Paris. A new blood test could predict preeclampsia as early as the first trimester.

Opinion: Racism infects neuroscience’s past and present. What about its future?

STAT

DECEMBER 20, 2023

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke. He is also trying to fight the long legacy of racism in neuroscience.

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

STAT

SEPTEMBER 17, 2024

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department.

Medical Schools

Medical Schools Hospitals

Opioid cravings were reduced by anti-obesity drug in small study

STAT

FEBRUARY 17, 2024

DENVER — The GLP-1 medication liraglutide significantly reduced opioid cravings in a small analysis presented on Saturday. It is the first randomized controlled trial to test anti-obesity drugs against opioid addiction, which kills around 80,000 people in the U.S. Read the rest…

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT

APRIL 29, 2025

Now, hundreds of thousands of patients are stuck navigating uncharted waters as companies they entrusted with their health pursue strategies that may disrupt their care or present risks. Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: How to eliminate biotech zombies: Buy them

STAT

FEBRUARY 27, 2025

Presently, Tang, via his hedge fund Tang Capital Partners and his privately held shell company, Concentra Biosciences, has a $3-per-share cash offer on the table to acquire and shut down Acelyrin, the distressed, cash-rich biotech that is seeking a second life as a merger partner with another troubled biotech.

Drug Development

STAT+: Otsuka tops Vera Therapeutics in kidney disease study showdown

STAT

JUNE 6, 2025

The results presented Friday achieved the interim goal of a Phase 3 study and were numerically superior to study results posted Monday by competitor Vera Therapeutics. A monthly treatment from Otsuka reduced by more than half the levels of a toxic protein in the urine of patients with an autoimmune kidney disease.

Drug Development

STAT+: Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug

STAT

MARCH 5, 2025

But in a clinical trial presented last year , 14 out of 50 patients with relapsed disease saw their tumors shrink. It responds poorly to chemotherapy and is usually driven by a mutation that can’t be drugged with traditional approaches. Median survival is generally cited as less than a year.

Chemotherapy

Chemotherapy Drug Development

STAT+: Nvidia says a biological revolution is happening now. But is it?

STAT

JANUARY 9, 2024

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. ” When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

Dietary experts advise skipping guidelines on ultra-processed foods — for now

STAT

OCTOBER 21, 2024

Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture. The results will be published in December.

STAT+: A GPT-powered medical device certified in Europe raises questions about generative AI in health care

STAT

JULY 3, 2025

One report presented at the meeting showed that a generative AI tool supposedly used by 40% of the radiology practices in the U.S. Last fall, a group of experts advising the U.S. Food and Drug Administration debated for two days on how to regulate generative artificial intelligence tools in medicine.

STAT+: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial

STAT

JUNE 3, 2024

CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early clinical data presented Monday at the American Society of Clinical Oncology annual meeting.

STAT+: Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

STAT

OCTOBER 25, 2023

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous infusion, according to study results presented Wednesday by its maker, Eisai.

STAT+: Could kidney transplant patients be spared a lifetime of immunosuppressants?

STAT

NOVEMBER 2, 2023

These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark. Continue to STAT+ to read the full story…

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

STAT

JANUARY 29, 2024

Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. LONDON — There was something odd about these Alzheimer’s cases. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease.

Documentation

Palliative care for cancer patients is found to be as effective given virtually as in person

STAT

JUNE 2, 2024

CHICAGO — Comfort can be delivered to patients with advanced cancer virtually just as well as in person, according to a new study presented on Sunday at the American Society of Clinical Oncology annual meeting in Chicago.

Hospitals

The fight for control of methadone, addiction treatment’s ‘miracle molecule’

STAT

OCTOBER 20, 2023

A doctor, a patient advocate, and the most powerful figure in the methadone treatment industry presented competing visions for the future of American addiction medicine this week — a conversation that touched on stigma, patients’ rights, and a stark divide in health provider attitudes toward patients with addiction.

STAT+: With an old approach but new energy, ADCs take center stage as promising cancer treatments

STAT

OCTOBER 24, 2023

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting , a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

Compounding

Compounding Drug Development

Opinion: Functional neurological disorder is not an appropriate diagnosis for people with long Covid

STAT

JULY 15, 2024

Long Covid — the name adopted for cases of prolonged symptoms after an acute bout of Covid-19 — is an umbrella diagnosis covering a broad range of clinical presentations and abnormal biological processes.

SAEM Clinical Images Series: Purple Finger

ALiEM - Pharm Pearls

MARCH 18, 2024

A 30-year-old female with a past medical history of Crohn’s Disease presented to the ED for evaluation of an acutely bruised right 4th finger. She stated she was typing on a computer keyboard approximately 10 minutes prior to presentation and she noticed a sudden popping sensation at the base of her right ring finger.

STAT+: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales

STAT

OCTOBER 2, 2024

NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post-presentation cocktail reception. If the sleep tech magnate could have used more shuteye, he didn’t show it.

STAT+: Corbus reports first Western data for closely tracked ADC cancer drug

STAT

FEBRUARY 14, 2025

Corbus Pharmaceuticals on Friday presented new data from the first Western study of its antibody-drug conjugate treatment for cancer that largely mirrored previous results reported from China. A CRB-701 study from China presented last June showed a 28% tumor response rate from 25 evaluable patients with fewer types of cancer.

Drug Development

Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry

STAT

JANUARY 11, 2024

Somehow, between back-to-back meetings and presentations, I’d have to bust out that abominable contraption and do my thing. But skipping a session ends up being even more painful. Naturally, I expected navigating the J.P. Morgan Healthcare Conference in San Francisco would be more complicated this year.

STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys

STAT

OCTOBER 27, 2023

The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases. Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys.

Surge of respiratory disease in China triggers anxiety, but experts see likely explanation

STAT

NOVEMBER 23, 2023

But at present, a number of experts say the activity has a likely explanation: China’s population, especially its young children, probably developed significant immunological susceptibility to a range of respiratory pathogens during the years of China’s zero Covid policy.

STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal

STAT

SEPTEMBER 5, 2024

Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as HARMONi-2. Sunday’s HARMONi-2 presentation at the World Conference on Lung Cancer should provide the answers. Continue to STAT+ to read the full story…

STAT+: Relay Therapeutics drug shows promise in early trial

STAT

SEPTEMBER 8, 2022

The results were released in an abstract at the annual meeting of the European Society of Molecular Oncology, where they will be presented in full on Sunday. Continue to STAT+ to read the full story…

Pandemic-related immunity gap in kids explains surge of respiratory infections in children in China, says WHO

STAT

NOVEMBER 24, 2023

The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic. Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among infectious disease watchers.

Immunity

Immunity Immunization

Can MRIs ensure prostate cancer screening does more good than harm?

STAT

SEPTEMBER 25, 2024

Prostate cancer presents a tricky screening challenge. Catching it early could mean dodging a painful journey with advanced cancer.

Takeda presents positive results from trial of chronic kidney disease treatment

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

Trending Sources

STAT+: How Pfizer used wearables to tap into the promise of an experimental drug

Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData

Levicept presents new LEVI-04 data at EULAR

STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present

Opinion: Diagnostic tests for rare conditions present a mathematical conundrum

Argenx presents new efgartigimod data at EULAR 2025

STAT+: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results

STAT+: Cigna, Centene, Walgreens drop out of J.P. Morgan conference

Article presents innovative drug for controlling weight and blood sugar

Experts say leaked messages present false link between gender-affirming care and cancer

STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition

Vertex presents promising new data from cystic fibrosis trials

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT+: New blood test could predict preeclampsia in the first trimester

Opinion: Racism infects neuroscience’s past and present. What about its future?

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

Opioid cravings were reduced by anti-obesity drug in small study

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT+: How to eliminate biotech zombies: Buy them

STAT+: Otsuka tops Vera Therapeutics in kidney disease study showdown

STAT+: Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug

STAT+: Nvidia says a biological revolution is happening now. But is it?

Dietary experts advise skipping guidelines on ultra-processed foods — for now

STAT+: A GPT-powered medical device certified in Europe raises questions about generative AI in health care

STAT+: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial

STAT+: Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

STAT+: Could kidney transplant patients be spared a lifetime of immunosuppressants?

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

Palliative care for cancer patients is found to be as effective given virtually as in person

The fight for control of methadone, addiction treatment’s ‘miracle molecule’

STAT+: With an old approach but new energy, ADCs take center stage as promising cancer treatments

Opinion: Functional neurological disorder is not an appropriate diagnosis for people with long Covid

SAEM Clinical Images Series: Purple Finger

STAT+: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales

STAT+: Corbus reports first Western data for closely tracked ADC cancer drug

Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry

STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys

Surge of respiratory disease in China triggers anxiety, but experts see likely explanation

STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal

STAT+: Relay Therapeutics drug shows promise in early trial

Pandemic-related immunity gap in kids explains surge of respiratory infections in children in China, says WHO

Can MRIs ensure prostate cancer screening does more good than harm?

Stay Connected